Literature DB >> 19028697

IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway.

Guodong Hu1, Betsy J Barnes.   

Abstract

The efficient and regulated response to cellular stress is coordinated by a genetic regulatory network in which a given transcription factor controls the expression of diverse target genes depending on the cell type and/or nature of the stimuli. The tumor suppressor p53 is thought to preferentially regulate the balance between cell survival and death. The interferon regulatory factor 5 (IRF-5), known to be involved in the innate immune response to pathogens, is also a critical regulator of DNA damage-induced apoptosis. Here, we provide direct evidence that IRF-5 promotes apoptosis upon signaling through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors (DR). We report that IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death that is further enhanced by type I interferons. Cells deficient of IRF-5 gave a significantly diminished response to these agents. IRF-5 is involved in DR signaling upstream of caspase 8, in part because of an IRF-5-dependent increase in caspase 8 activation. We provide evidence that TRAIL induces a signaling cascade that leads to the phosphorylation and nuclear localization of IRF-5, resulting in transactivation of key DR signaling components. The results presented here identify IRF-5 as a new mediator of DR signaling and provides molecular insight into the mechanism of TRAIL-induced IRF-5 signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028697     DOI: 10.1074/jbc.M804744200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

Review 2.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

3.  Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.

Authors:  Audrey Vincent; Noriyuki Omura; Seung-Mo Hong; Andrew Jaffe; James Eshleman; Michael Goggins
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

4.  The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability.

Authors:  Justyna Korczeniewska; Betsy J Barnes
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

5.  Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.

Authors:  Kei Yasuda; Kerstin Nündel; Amanda A Watkins; Tania Dhawan; Ramon G Bonegio; Jessalyn M Ubellacker; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  Int Immunol       Date:  2013-01-04       Impact factor: 4.823

6.  Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons.

Authors:  Rivka C Stone; Di Feng; Jing Deng; Sukhwinder Singh; Lisong Yang; Patricia Fitzgerald-Bocarsly; Maija-Leena Eloranta; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2012-03

7.  IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.

Authors:  Amanda A Watkins; Kei Yasuda; Gabriella E Wilson; Tamar Aprahamian; Yao Xie; Elena Maganto-Garcia; Prachi Shukla; Lillian Oberlander; Bari Laskow; Hanni Menn-Josephy; Yuanyuan Wu; Pierre Duffau; Susan K Fried; Andrew H Lichtman; Ramon G Bonegio; Ian R Rifkin
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

8.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

9.  Death receptor 5-targeted depletion of interleukin-23-producing macrophages, Th17, and Th1/17 associated with defective tyrosine phosphatase in mice and patients with rheumatoid arthritis.

Authors:  Jun Li; PingAr Yang; Qi Wu; Hao Li; Yanna Ding; Hui-Chen Hsu; David M Spalding; John D Mountz
Journal:  Arthritis Rheum       Date:  2013-10

10.  Corrected and Republished from: The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability.

Authors:  Justyna Korczeniewska; Betsy J Barnes
Journal:  Mol Cell Biol       Date:  2018-01-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.